Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
1.98% INR1 122.90
America/New_York / 8 mai 2024 @ 05:59
FUNDAMENTALS | |
---|---|
MarketCap: | 6 408.57 mill |
EPS: | 116.11 |
P/E: | 9.67 |
Earnings Date: | May 13, 2024 |
SharesOutstanding: | 5.71 mill |
Avg Daily Volume: | 0.0106 mill |
RATING 2024-05-08 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Strong Buy | |
Return On Asset: | Neutral | |
DE: | Sell | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 9.67 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 9.67 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
INR1 286.47 (14.57%) INR163.57 |
Date: 2024-05-08 |
Expected Trading Range (DAY) |
---|
INR 1 069.14 - 1 176.66 ( +/- 4.79%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | INR1 122.90 (1.98% ) |
Volume | 0.0054 mill |
Avg. Vol. | 0.0106 mill |
% of Avg. Vol | 50.57 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.